Eli Lilly & Co. has won its case in Federal court in Delaware where it sought to protect its patent for the drug Alimta. Alimta (pemetrexed for injection) now marketed by Eli Lilly & Co. (“Lilly”) was developed in clinical trials by Lilly in the early 1990s after it was discovered that disodium pemetrexed, the [...]
Tags: alimta, chemotherapy, Cisplatin, clinical trial, Eli Lilly & Co., malignant pleural mesothelioma, national cancer institute, Pemetrexed